Publications by authors named "Megan Ehret"

Claim this Profile
R
Real-world longitudinal treatment trajectories following opioid use disorder diagnosis among commercially-insured beneficiaries in the United States.
John G Rizk, Danya M Qato, Jannat Saini, Uzma Pathan, Bethany DiPaula, Megan Ehret

J Subst Use Addict Treat· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Trial of an Extension for Community Healthcare Outcomes (ECHO) Tele-mentoring Program to Increase Clozapine Utilization.
Deanna L Kelly, Jared Hunt, Gopal Vyas, Matthew Glassman, Clayton H Brown, Megan J Ehret

Schizophr Bull· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Training student pharmacists to administer long-acting injectable medications.
Megan J Ehret, Raymond C Love, Bethany DiPaula

Ment Health Clin· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving clozapine utilization will require continued advocacy, drug sponsor interest, and FDA support to address REMS issues.
Jonathan G Leung, Megan Ehret, Raymond C Love, Robert O Cotes

Expert Rev Clin Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.
Jim Pheils, Megan J Ehret

Am J Health Syst Pharm· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of posttraumatic stress disorder: Focus on pharmacotherapy.
Megan Ehret

Ment Health Clin· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aripiprazole Lauroxil NanoCrystal Dispersion Technology (Aristada Initio ).
Megan J Ehret, Erica Davis, Sarah E Luttrell, Caroline Clark

Clin Schizophr Relat Psychoses· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Practices in the Treatment of Alzheimer Disease: Where is the Evidence After the Phase III Trials?
Megan J Ehret, Kevin W Chamberlin

Clin Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylphenidate and dexmethylphenidate formulations for children with attention-deficit/hyperactivity disorder.
David Sugrue, Robin Bogner, Megan J Ehret

Am J Health Syst Pharm· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BDNF Val66Met polymorphism and lithium response: a meta-analysis.
Megan J Ehret, William Baker, Hannah O'Neill

Per Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication adherence among female inmates with bipolar disorder: results from a randomized controlled trial.
Megan J Ehret, Deborah Shelton, William Barta, Robert Trestman, Annette Maruca

Psychol Serv· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vilazodone: a novel antidepressant.
Elizabeth Choi, Monika Zmarlicka, Megan J Ehret

Am J Health Syst Pharm· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis.
Megan Ehret, John Goethe, Michael Lanosa, Craig I Coleman

J Clin Psychiatry· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological treatment of bipolar depression.
Megan J Ehret

Conn Med· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
Benjamin Chavez, Michael A Sopko, Megan J Ehret, Raphael E Paulino, Kyle R Goldberg

Ann Pharmacother· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychopharmacology: much the same.
Marina Grgas, Megan J Ehret

Conn Med· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desvenlafaxine: another "me too" drug?
Michael A Sopko, Megan J Ehret, Marina Grgas

Ann Pharmacother· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness.
Gary M Levin, Toya M Bowles, Megan J Ehret, Taimour Langaee, Jennifer Y Tan

Mol Diagn Ther· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term use of atypical antipsychotics in bipolar disorder.
Megan J Ehret, Gary M Levin

Pharmacotherapy· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-acting injectable risperidone.
Megan J Ehret, Matthew A Fuller

Ann Pharmacother· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis